Orchid Advisors – Trademark Portfolio
Entity Type: 03
Orchid Advisors holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ORCHID PAY, ORCHID EBOUND, ORCHID GUN SHOW, and ORCHID ERP ACCELERATOR. The owner is based in Unionville, CT.
27 Oakridge
Unionville, CT 06085
Showing of trademarks Trademarks
Trademark Classifications
Orchid Advisors's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Insurance; financial affairs; monetary affairs; real estate affairs
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Orchid Advisors have?
Orchid Advisors has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned, 1 cancelled.
What trademark classes does Orchid Advisors file in?
Orchid Advisors files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 36 (Insurance & Financial), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Orchid Advisors's most well-known trademarks?
Orchid Advisors's registered trademark portfolio includes well-known marks such as ORCHID PAY, ORCHID EBOUND, ORCHID GUN SHOW, and ORCHID ERP ACCELERATOR. These are among 4 currently registered trademarks in the portfolio.
What is Orchid Advisors's trademark registration success rate?
Orchid Advisors has a 67% trademark registration rate, with 4 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.